|
US3337530A
(en)
*
|
1965-09-20 |
1967-08-22 |
Upjohn Co |
Dinucleoside 3', 5' -and 2', 5'-phosphates containing one 7-deazapurin riboside moiety
|
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
|
US4921757A
(en)
*
|
1985-04-26 |
1990-05-01 |
Massachusetts Institute Of Technology |
System for delayed and pulsed release of biologically active substances
|
|
US4920016A
(en)
*
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
JPH0825869B2
(ja)
*
|
1987-02-09 |
1996-03-13 |
株式会社ビタミン研究所 |
抗腫瘍剤包埋リポソ−ム製剤
|
|
US4911928A
(en)
*
|
1987-03-13 |
1990-03-27 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
|
US4917951A
(en)
*
|
1987-07-28 |
1990-04-17 |
Micro-Pak, Inc. |
Lipid vesicles formed of surfactants and steroids
|
|
US5646265A
(en)
*
|
1990-01-11 |
1997-07-08 |
Isis Pharmceuticals, Inc. |
Process for the preparation of 2'-O-alkyl purine phosphoramidites
|
|
US5872242A
(en)
|
1992-10-05 |
1999-02-16 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide inhibition of ras
|
|
GB9301000D0
(en)
*
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
|
US6806061B1
(en)
|
1995-01-19 |
2004-10-19 |
Children's Medical Center Corporation |
G protein-coupled receptor gene and methods of use therefor
|
|
US5874211A
(en)
|
1995-04-13 |
1999-02-23 |
Incyte Pharmaceuticals, Inc. |
Chemokine expressed in eosinophils
|
|
FR2734147B1
(fr)
|
1995-05-19 |
1997-10-10 |
Klein Jean Michel |
Dispositif d'osteosynthese implantable
|
|
US6825174B2
(en)
*
|
1995-06-07 |
2004-11-30 |
East Carolina University |
Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
|
|
US6025339A
(en)
*
|
1995-06-07 |
2000-02-15 |
East Carolina University |
Composition, kit and method for treatment of disorders associated with bronchoconstriction and lung inflammation
|
|
FR2742156A1
(fr)
|
1995-12-06 |
1997-06-13 |
Sanofi Sa |
Polypeptide recepteur de l'il-13
|
|
US6265184B1
(en)
|
1995-12-20 |
2001-07-24 |
Icos Corporation |
Polynucleotides encoding chemokine receptor 88C
|
|
US6229006B1
(en)
|
1995-12-22 |
2001-05-08 |
Smithkline Beecham Corporation |
Use of antisense oligodeoxynucleotides to produce truncated proteins
|
|
AUPN780096A0
(en)
|
1996-01-30 |
1996-02-22 |
Medvet Science Pty. Ltd. |
Cytokine antagonists and agonists
|
|
EP1012190A4
(en)
|
1996-04-26 |
2004-04-28 |
Merck & Co Inc |
Eotaxin receptor from eosinophils
|
|
WO1997041225A2
(en)
|
1996-04-26 |
1997-11-06 |
Incyte Pharmaceuticals, Inc. |
Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr]
|
|
US5807708A
(en)
*
|
1996-07-30 |
1998-09-15 |
Millennium Pharmaceuticals, Inc. |
Conservin nucleic acid molecules and compositions
|
|
CA2304312A1
(en)
|
1997-09-17 |
1999-03-25 |
East Carolina University |
Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
|
|
CA2235420A1
(en)
*
|
1998-06-17 |
1999-12-17 |
Paolo Renzi |
Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
|
|
DE69934227T2
(de)
|
1998-06-19 |
2007-10-04 |
Mcgill University, Montreal |
Auf Beta-Arabinose und dessen Analoga basierte Antisense-Oligonukleotide
|
|
HK1042706A1
(zh)
|
1998-08-03 |
2002-08-23 |
东卡罗来纳大学 |
低腺苷反义寡核苷酸制剂、组合物、试剂盒及处理
|
|
US6175004B1
(en)
|
1998-09-01 |
2001-01-16 |
Isis Pharmaceuticals, Inc. |
Process for the synthesis of oligonucleotides incorporating 2-aminoadenosine
|
|
BR0006019A
(pt)
|
1999-04-06 |
2001-03-13 |
Univ East Carolina |
Oligonucleotìdeo de anti-sentido de adenosina baixo, composições, kit & método para tratamento de distúrbios de vias aéreas associados com broncoconstricção, inflamação pulmonar, alergia(s) & depleção de surfactante
|
|
EP1315807B1
(en)
|
2000-09-06 |
2005-04-20 |
McGILL UNIVERSITY |
Chimeric antisense oligonucleotides of arabinofuranose analogues and deoxyribose nucleotides
|
|
US20020151064A1
(en)
*
|
2001-02-07 |
2002-10-17 |
Children's Hospital Medical Center |
Regulation of CCR3 expression
|
|
WO2003004511A2
(en)
*
|
2001-07-06 |
2003-01-16 |
Topigen Pharmaceutique Inc.. |
Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
|
|
CA2465129A1
(en)
|
2001-10-29 |
2003-05-08 |
Mcgill University |
Acyclic linker-containing oligonucleotides and uses thereof
|
|
US8278103B2
(en)
|
2002-02-01 |
2012-10-02 |
Mcgill University |
Oligonucleotides comprising alternating segments and uses thereof
|